JHS Svendgaard Laboratories Limited

NSE JHS.NS

JHS Svendgaard Laboratories Limited Price to Sales Ratio (P/S) on January 14, 2025: 2.34

JHS Svendgaard Laboratories Limited Price to Sales Ratio (P/S) is 2.34 on January 14, 2025, a -0.33% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

JHS Svendgaard Laboratories Limited 52-week high Price to Sales Ratio (P/S) is 3.67 on September 18, 2024, which is 56.78% above the current Price to Sales Ratio (P/S).
JHS Svendgaard Laboratories Limited 52-week low Price to Sales Ratio (P/S) is 1.28 on March 27, 2024, which is -45.13% below the current Price to Sales Ratio (P/S).
JHS Svendgaard Laboratories Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 2.54.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: JHS.NS

JHS Svendgaard Laboratories Limited

CEO	Mr. Paramvir Singh Pabla
IPO Date	Oct. 23, 2006
Location	India
Headquarters	B-1/E-23, Mohan Co-operative Indu. Area
Employees	250
Sector	Health Care
Industries Dental Care Cosmetics Pharmaceuticals

Description

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture products under the Dr. Gold and Aquawhite brands. It also provides contract manufacturing services for oral care products of other brands; and operates retail stores at airports. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1996 and is based in New Delhi, India.

Key trends

Past 5 years